aspr

HHS, Industry Partners Expand U.S.-Based Pharmaceutical Manufacturing for COVID-19 Response

[advanced_iframe src=»https://view.connect.hhs.gov/?qs=e978c99dd50b96d67b3069af3c69310e0151227634f8a819fda4bef1c9386452030eb127cbada27537820aaef13ea2078ecff7d53d240baf8da8ef1927bf45ff85a31ba114b162de» width=»100%» height=»2600″]